PANGYO, South Korea--(BUSINESS WIRE)-- #AntibodyTherapeutics--Huonslab, the R&D subsidiary of Huons Global, secured patents and PCT filings for 11 SC antibody formulations using HyDIFFUZETM.
Huonslab Secures Patent for Subcutaneous Injection Formulation Comprising Therapeutic Antibody and ‘HyDIFFUZETM’ Platform
